Viz.ai gets FDA nod for cardiomyopathy algorithm
Artificial intelligence (AI) software developer Viz.ai has secured de novo approva...Read more on AuntMinnie.comRelated Reading:
Viz.ai nets FDA nod for AAA detection algorithm
Viz.ai to use recruiting platform for pulmonary embolism trial
Viz.ai inks deal with Bristol Meyers to deploy AI
Viz.ai teams up with Johns Hopkins
Viz.ai, TeleSpecialists tout study presented at ISC
Source: AuntMinnie.com Headlines - Category: Radiology Source Type: news